FDA is urged to increase regulatory oversight over tanning beds

12/14/2012 | Hill, The

The American Cancer Society is calling on federal officials to subject tanning beds to greater FDA oversight due to findings that the devices are associated with an increased risk of skin cancer. Makers of tanning beds contend there has been no proof of a link between their products and fatal cancers.

View Full Article in:

Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC